German biotechnology company, Topas Therapeutics, has signed a multi-year agreement with Eli Lilly and Company, which will see the companies collaborate to generate drug candidates in the field of antigen specific tolerance induction. more

22 Aug 2017 10:26 News

An agreement between Crown Bioscience (CrownBio) and The Jackson Laboratory (JAX) has been announced to improve the development and accessibility of innovative research models and pre-clinical services to the global biomedical research community. more

21 Jun 2017 11:43 News

An agreement between Fortress Biotech subsidiary, Caelum Biosciences, and Patheon has been made that will involve the process development and cGMP production of CAEL-101 more

2 Jun 2017 15:22 News